PapersPMID:40676704
Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →- No detected effect on body mass
moderate
“As shown in Table 2, both the BL21 group (P = 0.02) and placebo group (P = 0.01) demonstrated significant body weight reductions, with no statistically significant intergroup difference observed (P = 0.81).”
- Study
- RCT
- Duration
- 8 weeks
- Interests
- Industry funded
- Dose studied
- once daily for 8 weeks, 2 × 1010 CFU/day with 3 g maltodextrin per day, oral powder
- Population
- Overweight and obese adults aged 18-65 (BMI above 24 kg/m2); per-protocol set of 33 per arm; placebo was maltodextrin
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- overweight and obese adults aged 18 to 65 years with BMI above 24 kg/m2
- Participants
- 72
- Comparator
- placebo
- Duration
- 56 days
- Endpoints measured
- 31